Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

213
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
213
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

488
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
488
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

216
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
216
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

518
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
518
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

278
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
278
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

436
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
436

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Instrument selection for the assessment of peripheral arthritis in axial and peripheral spondyloarthritis: an ASAS project.

Annals of the rheumatic diseases·2026
Same author

Bimekizumab Long-Term Safety and Efficacy Across the Spectrum of Axial Spondyloarthritis Over 3 Years: Results from Two Phase 3 Studies.

The Journal of rheumatology·2026
Same author

Choosing NSAID treatment in axial spondyloarthritis: factors guiding clinical decision-making.

Current opinion in rheumatology·2026
Same author

Impact of comorbidities and extra-musculoskeletal manifestations on radiographic progression in ankylosing spondylitis.

Rheumatology (Oxford, England)·2026
Same author

No major effect of age (< 40 vs. ≥ 40 years) on response to secukinumab in patients with axSpA: a post hoc analysis of six phase 3 trials.

Arthritis research & therapy·2026
Same author

Antinuclear antibody testing in hospitalized patients with headache: The importance of clinical context.

Headache·2026

Related Experiment Video

Updated: Jan 3, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.9K

A latent class based imputation method under Bayesian quantile regression framework using asymmetric Laplace

Minjae Lee1, Mohammad H Rahbar1,2, Lianne S Gensler3

  • 1Division of Clinical and Translational Sciences, Department of Internal Medicine, University of Texas McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas, USA.

Journal of Biopharmaceutical Statistics
|November 16, 2019
PubMed
Summary
This summary is machine-generated.

This study introduces a novel Bayesian quantile regression method using latent class multiple imputation to accurately analyze longitudinal medication data with missing values. The approach improves understanding of treatment effects in complex patient populations.

Keywords:
Bayesian quantile regressionMultiple imputationasymmetric Laplace distributionintermittent missinglatent classprospective study of outcomes in ankylosing spondylitis (PSOAS)

More Related Videos

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.0K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.7K

Related Experiment Videos

Last Updated: Jan 3, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.9K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.0K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.7K

Area of Science:

  • Biostatistics
  • Pharmacology
  • Epidemiology

Background:

  • Longitudinal studies are crucial for understanding disease progression and treatment effects.
  • Missing medication data in patient follow-ups complicates accurate analysis of treatment trajectories.
  • Inappropriate handling of missing data can bias estimations in regression models, especially with complex missingness mechanisms.

Purpose of the Study:

  • To develop and evaluate a novel statistical method for handling intermittently missing longitudinal medication usage data.
  • To improve the accuracy of estimating associations between disease progression and pharmacological therapy patterns.
  • To address unobserved heterogeneity in medication usage data within longitudinal studies.

Main Methods:

  • Proposed a latent class-based multiple imputation (MI) approach combined with Bayesian quantile regression (BQR).
  • Incorporated cluster analysis for unobserved heterogeneity in medication usage data.
  • Utilized simulation studies to compare the proposed method against traditional MI techniques.

Main Results:

  • Simulation findings demonstrated superior performance of the proposed method over traditional MI under specific data distributions.
  • The method effectively handled intermittently missing longitudinal medication data.
  • Applied the method to the Ankylosing Spondylitis (AS) cohort to analyze nonsteroidal anti-inflammatory drugs (NSAIDs) usage and radiographic damage.

Conclusions:

  • The proposed latent class-based MI with BQR offers a robust solution for analyzing longitudinal medication data with intermittent missingness.
  • This method provides more reliable estimations of treatment effects compared to traditional approaches in complex scenarios.
  • Demonstrated practical utility in a real-world cohort study for assessing disease-drug associations.